User profiles for "author:Kate Smolina"

Kate Smolina

Scientific Director, Data, Analytics & KT, BCCDC
Verified email at bccdc.ca
Cited by 2827

Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study

K Smolina, FL Wright, M Rayner, MJ Goldacre - Bmj, 2012 - bmj.com
Objective To report trends in event and case fatality rates for acute myocardial infarction and
examine the relative contributions of changes in these rates to changes in total mortality from …

Postmarket policy considerations for biosimilar oncology drugs

MJ Renwick, K Smolina, EJ Gladstone… - The Lancet …, 2016 - thelancet.com
Oncology biological products are some of the most expensive drugs on the market and are a
growing financial burden on patients and health-care systems. By 2020, numerous major …

Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010

K Smolina, FL Wright, M Rayner… - … Quality and Outcomes, 2012 - Am Heart Assoc
Background—There are limited population-based national data on prognosis in survivors of
acute myocardial infarction (AMI), particularly on long-term survival and the risk of …

[HTML][HTML] Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998–2011: a retrospective national record linkage cohort study

K Smolina, CJ Wotton, MJ Goldacre - Diabetologia, 2015 - Springer
Aims/hypothesis Type 2 diabetes increases the risk of subsequent dementia. Our objective
was to determine whether a similar risk of subsequent dementia is associated with type 1 …

Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults

SG Morgan, D Weymann, B Pratt, K Smolina… - Age and …, 2016 - academic.oup.com
Objectives: to measure sex differences in the risk of receiving potentially inappropriate
prescription drugs and to examine what are the factors that contribute to these differences …

[HTML][HTML] Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002–2011: a population-based cohort study

K Smolina, GE Hanley, B Mintzes, TF Oberlander… - PloS one, 2015 - journals.plos.org
Purpose To describe trends, patterns, and determinants of prescription drug use during
pregnancy and postpartum. Methods This is a retrospective, population-based study of all …

The Canadian Rx Atlas

S Morgan, K Smolina, D Mooney, C Raymond… - 2013 - open.library.ubc.ca
Abstract" Canadians spent almost $23-billion on prescription drugs at retail pharmacies in
2012/13–or over $650 per capita. That is a lot of money. However, after adjusting for general …

Sex disparities in post-acute myocardial infarction pharmacologic treatment initiation and adherence: problem for young women

K Smolina, L Ball, KH Humphries, N Khan… - … Quality and Outcomes, 2015 - Am Heart Assoc
Background—The prevalence of the use of secondary prevention cardiovascular
medications is lower among women than men, but it is unclear if this is a result of lower …

Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020

DM Skowronski, I Sekirov, S Sabaiduc, M Zou… - MedRxiv, 2020 - medrxiv.org
Abstract Background The province of British Columbia (BC) has been recognized for
successful SARS-CoV-2 control, with surveillance data showing amongst the lowest case …

[HTML][HTML] COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British …

T Bahremand, JA Yao, C Mill, J Piszczek… - The Lancet Regional …, 2023 - thelancet.com
Background People with immune dysfunction are at higher risk of severe outcomes from
COVID-19 infection, but relatively little epidemiologic information is available for mostly …